Загрузка...
Quality Comparison of Biosimilar and Copy Filgrastim Products with the Innovator Product
PURPOSE: Filgrastim, a recombinant human granulocyte-colony stimulating factor, is widely used to treat congenital and acquired neutropenia. Following patent expiration of the innovator filgrastim product, biosimilar filgrastim products have been approved in the EU and shown to be comparable with th...
Сохранить в:
| Опубликовано в: : | Pharm Res |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Springer US
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6182392/ https://ncbi.nlm.nih.gov/pubmed/30280277 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-018-2491-5 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|